Q32 Bio Newsroom

Express News | Q32 Bio Inc Shares Hit Record Low After Guggenheim Downgrades Stock, Last Down 21.2%

ReutersDec 12 12:00 ET

Q32 Bio Is Maintained at Outperform by BMO Capital

Dow JonesDec 12 11:27 ET · Ratings

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

Zacks Dec 12 10:35 ET

BMO Capital Maintains Q32 Bio(QTTB.US) With Buy Rating, Cuts Target Price to $22

Moomoo NewsDec 12 10:32 ET · Ratings

Guggenheim Downgrades Q32 Bio to Neutral

BenzingaDec 12 10:14 ET

Q32 Bio Analyst Ratings

BenzingaDec 12 10:07 ET · Ratings

Q32 Bio Price Target Lowered to $22 From $64 at BMO Capital

TipRanksDec 12 09:55 ET

Express News | Q32 Bio Inc : BMO Cuts Target Price to $22 From $64

ReutersDec 12 07:46 ET

Q32 Bio Price Target Lowered to $20 From $80 at Oppenheimer

Yahoo FinanceDec 12 07:45 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaDec 11 16:06 ET

Top Midday Decliners

MT NewswiresDec 11 14:00 ET

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT NewswiresDec 11 13:50 ET

Q32 Bio Shares Plummet After Downgrades, Price Target Cuts

MT NewswiresDec 11 12:34 ET

Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday?

BenzingaDec 11 11:32 ET

Guggenheim Downgrades Q32 Bio(QTTB.US) to Hold Rating

Moomoo NewsDec 11 11:31 ET · Ratings

Q32 Stock Craters 68% on Mixed Phase 2 Data for Bempikibart

Seeking AlphaDec 11 11:08 ET

Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations

BenzingaDec 11 10:46 ET

Guggenheim Downgrades Q32 Bio to Neutral From Buy; Shares Plummet

MT NewswiresDec 11 10:44 ET

Q32 Bio Tanks 68% After Update On Its Eczema And Alopecia Treatment

RTTNewsDec 11 10:16 ET

Q32 Bio Shares Plunge On Data From Bempikibart Trials In Atopic Dermatitis And Alopecia Areata

RTTNewsDec 11 10:05 ET